Increased circulating phenylacetylglutamine concentration elevates the predictive value of cardiovascular event risk in heart failure patients
Haoran Wei(Tongji Hospital), Dao Wen Wang(Tongji Hospital), Lei Xiao(Xinjiang Medical University), Liyuan Peng(Tongji Hospital), Zhitong Zhou(Jiangnan University), Junfang Wu(Laboratory of Molecular Genetics), Yang Sun(National University of Singapore), Huiqing Wang(Guangdong Pharmaceutical University), Chunxia Zhao(The University of Adelaide), Jin Huang(Shenzhen Pingle Orthopedic Hospital), Chenze Li(Wuhan University), Yaonan Song(Tongji Hospital), Yuxuan Zhang(Tongji Hospital)
Cited by 28
Related Papers
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
|Nature Communications|2014|422
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
Gut Microbiota Composition Modifies Fecal Metabolic Profiles in Mice
|Journal of Proteome Research|2013|225
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
|Science China Life Sciences|2020|176